AAAAAA

   
Results: 1-19 |
Results: 19
ENDOSCOPIC BILIARY DRAINAGE BEFORE PANCREATICODUODENECTOMY FOR PERIAMPULLARY MALIGNANCIES
Authors: MARCUS SG DOBRYANSKY M SHAMAMIAN P COHEN H GOUGE TH PACHTER HL ENG K
Citation: Sg. Marcus et al., ENDOSCOPIC BILIARY DRAINAGE BEFORE PANCREATICODUODENECTOMY FOR PERIAMPULLARY MALIGNANCIES, Journal of clinical gastroenterology, 26(2), 1998, pp. 125-129
ACTIVATION OF TUMOR-CELL MATRIX METALLOPROTEINASE-2 BY NEUTROPHIL PROTEINASES REQUIRES EXPRESSION OF MEMBRANE-TYPE-1 MATRIX METALLOPROTEINASE
Authors: SCHWARTZ JD SHAMAMIAN P MONEA S WHITING D MARCUS SG GALLOWAY AC MIGNATTI P
Citation: Jd. Schwartz et al., ACTIVATION OF TUMOR-CELL MATRIX METALLOPROTEINASE-2 BY NEUTROPHIL PROTEINASES REQUIRES EXPRESSION OF MEMBRANE-TYPE-1 MATRIX METALLOPROTEINASE, Surgery, 124(2), 1998, pp. 232-238
SOLUBLE FACTOR(S) RELEASED FROM NEUTROPHILS ACTIVATES ENDOTHELIAL-CELL MATRIX METALLOPROTEINASE-2
Authors: SCHWARTZ JD MONEA S MARCUS SG PATEL S ENG K GALLOWAY AC MIGNATTI P SHAMAMIAN P
Citation: Jd. Schwartz et al., SOLUBLE FACTOR(S) RELEASED FROM NEUTROPHILS ACTIVATES ENDOTHELIAL-CELL MATRIX METALLOPROTEINASE-2, The Journal of surgical research (Print), 76(1), 1998, pp. 79-85
MAGNETIC-RESONANCE-IMAGING (MRI) WITH MAGNETIC-RESONANCE CHOLANGIOPANCREATOGRAPHY (MRCP) PREDICTS RESECTABILITY AND DUCTAL ABNORMALITIES INBENIGN AND MALIGNANT PANCREATIC DISEASE
Authors: HOCHWALD SN DOBRYANSKY M ROFSKY N SHAMAMIAN P MARCUS SG
Citation: Sn. Hochwald et al., MAGNETIC-RESONANCE-IMAGING (MRI) WITH MAGNETIC-RESONANCE CHOLANGIOPANCREATOGRAPHY (MRCP) PREDICTS RESECTABILITY AND DUCTAL ABNORMALITIES INBENIGN AND MALIGNANT PANCREATIC DISEASE, Gastroenterology, 114(4), 1998, pp. 88-88
PREDICTING COMORBIDITY IN PATIENTS WITH PANCREATIC FISTULAS FOLLOWINGPANCREATICODUODENECTOMY
Authors: KARPOFF HM SIVAMURTHY N OH C GOUGE TH PACHTER HL ENG K SHAMAMIAN P MARCUS SG
Citation: Hm. Karpoff et al., PREDICTING COMORBIDITY IN PATIENTS WITH PANCREATIC FISTULAS FOLLOWINGPANCREATICODUODENECTOMY, Gastroenterology, 114(4), 1998, pp. 113-113
MATRIX METALLOPROTEINASE (MMP)-2 AND (MMP)-9 ACTIVITY IN EXPERIMENTALACUTE-PANCREATITIS
Authors: PATEL S SCHWARTZ J CHAUNG N MARCUS SG PACHTER HL DEUTSCH E GALLOWAY AC ENG K MIGNATTI P SHAMAMIAN P
Citation: S. Patel et al., MATRIX METALLOPROTEINASE (MMP)-2 AND (MMP)-9 ACTIVITY IN EXPERIMENTALACUTE-PANCREATITIS, Gastroenterology, 114(4), 1998, pp. 188-188
ACTIVATION OF ENDOTHELIAL OR TUMOR-CELL PROGELATINASE-A (MMP-2) BY HUMAN POLYMORPHONUCLEAR NEUTROPHILS (PMN)
Authors: SCHWARTZ JD MONEA S SHAMAMIAN P MARCUS SG WHITING D GALLOWAY AC MIGNATTI P
Citation: Jd. Schwartz et al., ACTIVATION OF ENDOTHELIAL OR TUMOR-CELL PROGELATINASE-A (MMP-2) BY HUMAN POLYMORPHONUCLEAR NEUTROPHILS (PMN), Molecular biology of the cell, 8, 1997, pp. 435-435
PHASE-II TRIAL OF GLI-328 HSV-TK GENE-THERAPY IN RECURRENT GLIOBLASTOMA
Authors: BERGER MS PRADOS MD VANGILDER JC WARNICK RE MCDERMOTT MW MARCUS SG KAPCALA LP
Citation: Ms. Berger et al., PHASE-II TRIAL OF GLI-328 HSV-TK GENE-THERAPY IN RECURRENT GLIOBLASTOMA, Cancer gene therapy, 4(6), 1997, pp. 102-102
SERIAL MR IN GENE-THERAPY FOR RECURRENT GLIOBLASTOMA - INITIAL EXPERIENCE AND WORK-IN-PROGRESS
Authors: DELIGANIS AV BAXTER AB BERGER MS MARCUS SG MARAVILLA KR
Citation: Av. Deliganis et al., SERIAL MR IN GENE-THERAPY FOR RECURRENT GLIOBLASTOMA - INITIAL EXPERIENCE AND WORK-IN-PROGRESS, American journal of neuroradiology, 18(8), 1997, pp. 1401-1406
LEXIPAFANT INHIBITS PLATELET-ACTIVATING-FACTOR ENHANCED NEUTROPHIL FUNCTIONS
Authors: SCHWARTZ JD SHAMAMIAN P GROSSI EA SCHWARTZ DS MARCUS SG STEINER F JACOBS CE TAYYARAH M ENG K COLVIN SB GALLOWAY AC
Citation: Jd. Schwartz et al., LEXIPAFANT INHIBITS PLATELET-ACTIVATING-FACTOR ENHANCED NEUTROPHIL FUNCTIONS, The Journal of surgical research, 69(2), 1997, pp. 240-248
USE OF DOUBLE MARKING WITH RETROVIRAL VECTORS TO DETERMINE RATE OF RECONSTITUTION OF UNTREATED AND CYTOKINE EXPANDED CD34(-CELLS IN PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION() SELECTED MARROW)
Authors: HESLOP HE BRENNER MK KRANCE RA BOWMAN L CUNNINGHAM JM RICHARDSON S ALEXANDER B HEIDEMAN R BOYETT JM MARCUS SG BERENSON R HEIMFELD S BROWN S
Citation: He. Heslop et al., USE OF DOUBLE MARKING WITH RETROVIRAL VECTORS TO DETERMINE RATE OF RECONSTITUTION OF UNTREATED AND CYTOKINE EXPANDED CD34(-CELLS IN PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION() SELECTED MARROW), Human gene therapy, 7(5), 1996, pp. 655-667
OPTIMAL MANAGEMENT OF THE PANCREATIC REMNANT AFTER PANCREATICODUODENECTOMY
Authors: MARCUS SG COHEN H RANSON JHC
Citation: Sg. Marcus et al., OPTIMAL MANAGEMENT OF THE PANCREATIC REMNANT AFTER PANCREATICODUODENECTOMY, Annals of surgery, 221(6), 1995, pp. 635-648
THE USE OF INTERLEUKIN-6 TO GENERATE TUMOR-INFILTRATING LYMPHOCYTES WITH ENHANCED IN-VIVO ANTITUMOR-ACTIVITY
Authors: MARCUS SG PERRYLALLEY D MULE JJ ROSENBERG SA YANG JC
Citation: Sg. Marcus et al., THE USE OF INTERLEUKIN-6 TO GENERATE TUMOR-INFILTRATING LYMPHOCYTES WITH ENHANCED IN-VIVO ANTITUMOR-ACTIVITY, Journal of immunotherapy with emphasis on tumor immunology, 15(2), 1994, pp. 105-112
PULMONARY EMBOLECTOMY FOR INTRAVENOUS UTERINE LEIOMYOMATOSIS
Authors: MARCUS SG KRAUSS T FREEDBERG RS CULLIFORD AT WEINREICH DJ KRONZON I
Citation: Sg. Marcus et al., PULMONARY EMBOLECTOMY FOR INTRAVENOUS UTERINE LEIOMYOMATOSIS, The American heart journal, 127(6), 1994, pp. 1642-1645
HEMODYNAMIC-EFFECTS OF THE ADMINISTRATION OF TUMOR-INFILTRATING LYMPHOCYTES TO CANCER-PATIENTS
Authors: MARINCOLA FM BALKISSOON J SCHWARTZENTRUBER DJ HOM SS CONCEPCION R MARCUS SG YANNELLI J TOPALIAN SL PARKINSON DR ROSENBERG SA
Citation: Fm. Marincola et al., HEMODYNAMIC-EFFECTS OF THE ADMINISTRATION OF TUMOR-INFILTRATING LYMPHOCYTES TO CANCER-PATIENTS, Journal of immunotherapy with emphasis on tumor immunology, 13(4), 1993, pp. 282-288
SYSTEMIC RECOMBINANT HUMAN INTERFERON-BETA TREATMENT OF RELAPSING-REMITTING MULTIPLE-SCLEROSIS - PILOT-STUDY ANALYSIS AND 6-YEAR FOLLOW-UP
Authors: KNOBLER RL GREENSTEIN JI JOHNSON KP LUBLIN FD PANITCH HS CONWAY K GRANTGORSEN SV MULDOON J MARCUS SG WALLENBERG JC WILLIAMS GJ YOSHIZAWA CN
Citation: Rl. Knobler et al., SYSTEMIC RECOMBINANT HUMAN INTERFERON-BETA TREATMENT OF RELAPSING-REMITTING MULTIPLE-SCLEROSIS - PILOT-STUDY ANALYSIS AND 6-YEAR FOLLOW-UP, Journal of interferon research, 13(5), 1993, pp. 333-340
REGRESSION OF METASTATIC RENAL-CELL CARCINOMA AFTER CYTOREDUCTIVE NEPHRECTOMY
Authors: MARCUS SG CHOYKE PL REITER R JAFFE GS ALEXANDER RB LINEHAN WM ROSENBERG SA WALTHER MM
Citation: Sg. Marcus et al., REGRESSION OF METASTATIC RENAL-CELL CARCINOMA AFTER CYTOREDUCTIVE NEPHRECTOMY, The Journal of urology, 150(2), 1993, pp. 463-466
LONG-TERM OUTCOME IN 87 PATIENTS WITH LOW-GRADE SOFT-TISSUE SARCOMA
Authors: MARCUS SG MERINO MJ GLATSTEIN E DELANEY TF STEINBERG SM ROSENBERG SA YANG JC
Citation: Sg. Marcus et al., LONG-TERM OUTCOME IN 87 PATIENTS WITH LOW-GRADE SOFT-TISSUE SARCOMA, Archives of surgery, 128(12), 1993, pp. 1336-1343
HEPATIC-ABSCESS IN CANCER-PATIENTS - CHARACTERIZATION AND MANAGEMENT
Authors: MARCUS SG WALSH TJ PIZZO PA DANFORTH DN
Citation: Sg. Marcus et al., HEPATIC-ABSCESS IN CANCER-PATIENTS - CHARACTERIZATION AND MANAGEMENT, Archives of surgery, 128(12), 1993, pp. 1358-1364
Risultati: 1-19 |